| Mary Elizabeth Johnson, MD | |
|
2333 Buchanan St, San Francisco, CA 94115-1925 | |
| (209) 342-2300 | |
| (209) 524-4240 |
| Full Name | Mary Elizabeth Johnson |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 25 Years |
| Location | 2333 Buchanan St, San Francisco, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902887227 | NPI | - | NPPES |
| 00A751670 | Medicaid | CA | |
| 00A751670 | Other | CA | BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A75167 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Scripps Green Hospital | La jolla, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scripps Health | 9234033853 | 1362 |
News Archive
Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today the latest recipient of the End Duchenne Grant Award Program.
AVAC's annual report, titled "AVAC Report 2011: The End?," "is intended as a vision and a challenge to the field, and a first step in holding all of us - civil society, researchers, governments, and funders - accountable for progress" toward ending AIDS, according to the AVAC website (12/22).
Results from a study published in the journal Cancer Medicine show that a pragmatic system-based intervention within cancer treatment centers can eliminate existing disparities in treatment and outcomes for black patients with early-stage lung cancer across the U.S.
Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies.
Experts say women in Australia are at risk of dying from ovarian cancer because they are ignorant with regard to the symptoms.
› Verified 9 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780870899 PECOS PAC ID: 6406760131 Enrollment ID: O20031117000940 |
News Archive
Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today the latest recipient of the End Duchenne Grant Award Program.
AVAC's annual report, titled "AVAC Report 2011: The End?," "is intended as a vision and a challenge to the field, and a first step in holding all of us - civil society, researchers, governments, and funders - accountable for progress" toward ending AIDS, according to the AVAC website (12/22).
Results from a study published in the journal Cancer Medicine show that a pragmatic system-based intervention within cancer treatment centers can eliminate existing disparities in treatment and outcomes for black patients with early-stage lung cancer across the U.S.
Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies.
Experts say women in Australia are at risk of dying from ovarian cancer because they are ignorant with regard to the symptoms.
› Verified 9 days ago
| Entity Name | Scripps Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881636108 PECOS PAC ID: 9234033853 Enrollment ID: O20031124000822 |
News Archive
Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today the latest recipient of the End Duchenne Grant Award Program.
AVAC's annual report, titled "AVAC Report 2011: The End?," "is intended as a vision and a challenge to the field, and a first step in holding all of us - civil society, researchers, governments, and funders - accountable for progress" toward ending AIDS, according to the AVAC website (12/22).
Results from a study published in the journal Cancer Medicine show that a pragmatic system-based intervention within cancer treatment centers can eliminate existing disparities in treatment and outcomes for black patients with early-stage lung cancer across the U.S.
Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies.
Experts say women in Australia are at risk of dying from ovarian cancer because they are ignorant with regard to the symptoms.
› Verified 9 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578672184 PECOS PAC ID: 3577476761 Enrollment ID: O20031211000464 |
News Archive
Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today the latest recipient of the End Duchenne Grant Award Program.
AVAC's annual report, titled "AVAC Report 2011: The End?," "is intended as a vision and a challenge to the field, and a first step in holding all of us - civil society, researchers, governments, and funders - accountable for progress" toward ending AIDS, according to the AVAC website (12/22).
Results from a study published in the journal Cancer Medicine show that a pragmatic system-based intervention within cancer treatment centers can eliminate existing disparities in treatment and outcomes for black patients with early-stage lung cancer across the U.S.
Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies.
Experts say women in Australia are at risk of dying from ovarian cancer because they are ignorant with regard to the symptoms.
› Verified 9 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548667843 PECOS PAC ID: 6103739131 Enrollment ID: O20040121000458 |
News Archive
Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today the latest recipient of the End Duchenne Grant Award Program.
AVAC's annual report, titled "AVAC Report 2011: The End?," "is intended as a vision and a challenge to the field, and a first step in holding all of us - civil society, researchers, governments, and funders - accountable for progress" toward ending AIDS, according to the AVAC website (12/22).
Results from a study published in the journal Cancer Medicine show that a pragmatic system-based intervention within cancer treatment centers can eliminate existing disparities in treatment and outcomes for black patients with early-stage lung cancer across the U.S.
Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies.
Experts say women in Australia are at risk of dying from ovarian cancer because they are ignorant with regard to the symptoms.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Elizabeth Johnson, MD Po Box 232410, San Diego, CA 92193-2410 Ph: (209) 342-2300 | Mary Elizabeth Johnson, MD 2333 Buchanan St, San Francisco, CA 94115-1925 Ph: (209) 342-2300 |
News Archive
Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today the latest recipient of the End Duchenne Grant Award Program.
AVAC's annual report, titled "AVAC Report 2011: The End?," "is intended as a vision and a challenge to the field, and a first step in holding all of us - civil society, researchers, governments, and funders - accountable for progress" toward ending AIDS, according to the AVAC website (12/22).
Results from a study published in the journal Cancer Medicine show that a pragmatic system-based intervention within cancer treatment centers can eliminate existing disparities in treatment and outcomes for black patients with early-stage lung cancer across the U.S.
Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies.
Experts say women in Australia are at risk of dying from ovarian cancer because they are ignorant with regard to the symptoms.
› Verified 9 days ago
Paul Robinson, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1230 Arguello Blvd Apt 2, San Francisco, CA 94122 Phone: 415-948-8836 | |
Frederick D Pitts Jr., MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 229 7th St, San Francisco, CA 94103 Phone: 415-503-6042 Fax: 415-503-6099 | |
Georgina Lisseth Calderon, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 10th Ave, Apt. 1, San Francisco, CA 94122 Phone: 323-514-0964 | |
Timothy Bauer Duncan, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2333 Buchanan St, San Francisco, CA 94115 Phone: 209-342-2300 Fax: 209-524-4240 | |
Bichhuong M Dinh, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3555 Cesar Chavez, San Francisco, CA 94110 Phone: 240-447-1281 | |
Dr. Lauren Elizabeth Chalwell, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1001 Potrero Avenue Department Of Emergency Medicine, San Francisco General Hospital,, San Francisco, CA 94110 Phone: 415-206-5753 | |
Dr. Jeremy Lacocque, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Potrero Ave, San Francisco, CA 94110 Phone: 628-206-8000 |